See you in Boston! Oranssibio to Present Two High-Yield Cell Line Studies at the ASGCT 2026 Annual Meeting

BOSTON, May 13, 2026– The 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), a premier global event in the field of cell and gene therapy (CGT), is being held from May 11 to 14, 2026, in Boston, Massachusetts.

Oranssibio (formerly Huayuan (Shanghai) Biomedical Co., Ltd.), a CRDMO specializing in CGT process development and technological innovation, was invited to attend and presented its latest internally developed high-yield suspension cell line platforms for adeno-associated virus (AAV) and lentiviral (LV) vector production.

Through two high-quality scientific posters, Oranssibio systematically showcased key breakthroughs in its viral vector process platform innovations. These included the development of high-expressing suspension cell lines, significant improvements in vector yields, enhanced process stability, and seamless scalability for commercial manufacturing.

Leveraging its proprietary high-efficiency production platform, Oranssibio is committed to addressing persistent challenges in viral vector manufacturing, including low productivity and high costs. The company continues to advance the CGT drug manufacturing industry toward greater efficiency, higher quality, and lower cost, thereby supporting global clinical translation and commercial readiness.

Poster Presentation 1

• Poster Number: #2140
• Title: * Development of HEK293-ORB4D4: A High-yield Scalable Platform for rAAV Manufacturing *

Poster Presentation 2

• Poster Number: #2173
• Title: * HEK293T-ORB7D6: A Robust Suspension Cell Line for High-titer Lentiviral Vector Production *
• Presentation Time: May 13, 2026, 5:00 PM – 6:30 PM (Eastern Time)
• Location: Poster Hall, Thomas M. Menino Convention & Exhibition Center, Boston, MA, USA

About Oranssibio

Oranssibio is an innovative research, development, and manufacturing service provider dedicated to the field of cell and gene therapy (CGT). Leveraging its integrated CRO+CDMO platform, the company offers end-to-end services and support to biopharmaceutical companies and research institutions worldwide, covering early-stage research, process development, clinical sample production, and commercial-scale manufacturing.

Oranssibio has established high-yield, high-quality technology and manufacturing platforms across core areas including plasmids, viral vectors, cell therapy products, exosomes, and mRNA-LNP. The company is committed to accelerating the clinical translation of CGT drug candidates and significantly reducing CMC development and production costs for its clients.

Adhering to a "Quality First" philosophy, Oranssibio has implemented a quality management system compliant with NMPA, FDA, and EMA standards, ensuring GMP compliance, data integrity, and full traceability throughout the manufacturing process.

Through more efficient, robust, and cost-effective manufacturing platforms, Oranssibio aims to advance the industrialization of cell and gene therapies, making innovative treatments accessible to more patients worldwide.

About ASGCT

The 2026 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) is taking place from May 11 to 15, 2026, in Boston, Massachusetts, USA.

Founded in 1996, ASGCT is one of the most influential non-profit professional medical and scientific organizations in the field of gene and cell therapy, with thousands of members from research, clinical practice, and industry around the globe.

As one of the largest and most academically influential international conferences in the CGT field, the ASGCT Annual Meeting brings together leading research institutions, innovative biopharmaceutical companies, clinical experts, and industry pioneers worldwide. The conference showcases the latest breakthroughs in basic research, clinical advances, process development, and industrial translation, and is widely recognized as a key bellwether for the global CGT industry.

For more information, please visit the official meeting website:

https://annualmeeting.asgct.org/

Live from ASGCT Boston

If you are also in Boston, we warmly invite you to visit the Oranssibio booth and poster area for in-depth discussions:

Booth Number: #1074

Booth Location: Exhibit Hall, Thomas M. Menino Convention & Exhibition Center, 415 Summer St, Boston, MA 02210, USA

Contact Us

• Website: www.oranssibio.com
• Phone: (021) 57535558
• Email: bd@oranssibio.com